u/laila_yilmaz

switching from sema is not a dose conversion, there is no clean equivalence

Reference intervals are typically the central 95% of a reference population. By construction one person in twenty falls outside one on any given test without anything being wrong.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

Reported something here with dates and screenshots and was asked for the document trail. Fair challenge, and it made the report worth reading.

Did you come to this from sema, and if so how long was the gap?

Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.

screenshots are not evidence, dates and documents are

the counterion is part of the mass you paid for

the injection is easier than you are imagining

Is water content on the document? It changes your concentration arithmetic.

Related substances itemised individually is a much stronger document than a single total, because it tells you the shape of the impurity profile rather than its size.

Yes.

This is the check that catches most of it, and it takes under a minute.

the appetite effect is blunter than sema, in a good way, most weeks

What step are you on and how long have you been there?

Yes — nobody here is your clinician, and the good answers on this board all end with that.

What did the storefront say the lead time was?

Area percent or net peptide content? They answer different questions.

Nobody here can interpret your panel and this comment is not doing so. What a board can usefully do is help you ask better questions of somebody who can.

the review page nobody can find on any other site is a warning

Ask what the stability statement was written against — temperature, light, and whether it was the lyophilised powder or the reconstituted solution. Those are three different claims.

Push back: "nobody has tested them" is a fact about this board, not a fact about the company. Say the first one.

Read the phase 2 hepatic paper properly and the endpoint definitions were more interesting than the headline response rate.

Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.

Yes — 10mg being a genuine landing place for a lot of people is underrated. There is no medal for 15.

That is area percent from a certificate, not the amount of peptide in the vial. Two different numbers and a very common mix-up.

Agreed on asking for the storage condition. It is one line and it changes how you read the entire stability claim.

chromatogram or it did not happen

Nothing on this board is medical advice, and the people answering you — including me — are members with spreadsheets rather than clinicians.

Correction: the starting dose is a tolerance step rather than a treatment dose. The distinction is the answer to the question above.

Independent purity results for this compound are very sparse across the whole site, which means any impression about consistency is built on almost no

Agreed — and the endpoint definitions are where the actual claim lives.

Right, and net peptide content is where the counterion and the water go. Both numbers can be honest and very different.

Careful with the mechanism claim. Glucagon agonism is plausible as an explanation and it has not been isolated as the operative one.

the counterion is part of the mass you paid for

Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.

That is a non-fasting value and the interval you are comparing it against is a fasting one.

Yes — 10mg being a genuine landing place for a lot of people is underrated.

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.

redact your own name, never the batch details